Change search
ReferencesLink to record
Permanent link

Direct link
Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity.
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.
Show others and affiliations
2012 (English)In: Acta Oncologica, ISSN 0284-186X, E-ISSN 1651-226X, Vol. 51, no 1, 69-76 p.Article in journal (Refereed) Published
Abstract [en]

Abstract Background. Leucine-rich and immunoglobulin-like domains 1-3 (LRIG1-3) proteins have been implicated in the regulation of EGFR signalling. In the present study, we investigated the clinical implications of the expression of EGFR and LRIG1-3 in oesophageal carcinoma, as well as the correlation between their expression levels and the chemosensitivity of oesophageal carcinoma cell lines. Patients and methods. Tumours from 80 patients with oesophageal carcinoma were investigated for the expression of EGFR and LRIG proteins by immunohistochemistry. Oesophageal carcinoma cell lines were investigated for their expression of EGFR and LRIG1, 2, and 3 by quantitative real time RT-PCR and for their sensitivity to commonly used chemotherapeutics by a cytotoxicity assay. Results and discussion: Based on a total score of intensity and expression rates, a trend towards survival difference was found for EGFR (p = 0.09) and LRIG2 (p = 0.18) whereas for LRIG1 and -3 there was no trend towards any association with survival. Correlation analysis revealed a correlation with the clinical expression of EGFR and LRIG3 (p = 0.0007). Significant correlations were found between LRIG1 expression levels and sensitivity to cisplatin (r = -0.74), docetaxel (r = -0.69), and vinorelbine (r = -0.82) in oesophageal carcinoma cell lines. EGFR and the LRIG proteins may be functionally involved in oesophageal carcinoma, but larger materials are needed to fully elucidate the clinical implication.

Place, publisher, year, edition, pages
Informa Healthcare , 2012. Vol. 51, no 1, 69-76 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:umu:diva-43512DOI: 10.3109/0284186X.2011.562239PubMedID: 21417672OAI: oai:DiVA.org:umu-43512DiVA: diva2:414383
Available from: 2011-05-03 Created: 2011-05-03 Last updated: 2012-05-21Bibliographically approved

Open Access in DiVA

fulltext(358 kB)173 downloads
File information
File name FULLTEXT02.pdfFile size 358 kBChecksum SHA-512
f6fbf57bd5e93b6e514c723651e469080690f2a4525fd2d312e2cb33b067c0335765f3217ee54b9cbb6e50e46962564b86248ade8bc190b9a4ea2312073f1930
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Hedman, HåkanHenriksson, Roger
By organisation
Oncology
In the same journal
Acta Oncologica
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 173 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 109 hits
ReferencesLink to record
Permanent link

Direct link